Akari Therapeutics PLC · NASDAQ:AKTX

Farag Kameel D. received 2,873 Akari Therapeutics PLC shares as an award (Form 4)

Traded Nov 17, 2026 · Filed Nov 19, 2026

On Nov 17, 2026, Farag Kameel D. (Interim CFO) received 2,873 Akari Therapeutics PLC shares as an award at an average US$9.05 for US$25,992, leaving 26,182 shares. Filed Nov 19, 2026 (Form 4).

Awarded
2,873 shares
Price
US$9.05 average (US$8.18 to US$10.12)
Value
US$25,992
Holding after
26,182 shares
Trading plan
No
Role
Interim CFO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026American Depositary Shares representing Ordinary SharesAward1,284US$10.1224,593Direct
Nov 17, 2026American Depositary Shares representing Ordinary SharesAward1,589US$8.1826,182Direct

Source

Download original · View original at SEC

Related